Filing Details

Accession Number:
0001144204-19-003774
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-30 16:18:32
Reporting Period:
2019-01-28
Accepted Time:
2019-01-30 16:18:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1644963 Avenue Therapeutics Inc. ATXI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1298246 Neil Herskowitz C/O Avenue Therapeutics, Inc.
2 Gansevoort Street, 9Th Floor
New York NY 10014
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-28 1,447 $5.84 68,610 No 4 P Direct
Common Stock Acquisiton 2019-01-29 8,553 $5.91 77,163 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Reflects the weighted average purchase price of multiple same-day open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on January 28, 2019 was $5.82 to $5.89 and the range of prices for the purchase transactions on January 29, 2019 was $5.86 to $5.99. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. Includes 64,663 shares of restricted stock.